146 related articles for article (PubMed ID: 17469329)
21. Anti-tumor necrosis factor inhibitor therapy-induced dermatomyositis and fasciitis.
Riolo G; Towheed TE
J Rheumatol; 2012 Jan; 39(1):192-4. PubMed ID: 22210682
[No Abstract] [Full Text] [Related]
22. Drug-induced lupus due to anti-tumor necrosis factor alpha agents.
Costa MF; Said NR; Zimmermann B
Semin Arthritis Rheum; 2008 Jun; 37(6):381-7. PubMed ID: 17977585
[TBL] [Abstract][Full Text] [Related]
23. Adalimumab in juvenile rheumatoid arthritis.
Sfriso P; Ravaioli F
N Engl J Med; 2008 Dec; 359(23):2495; author reply 2496-7. PubMed ID: 19052133
[No Abstract] [Full Text] [Related]
24. Infliximab-induced lupus-like reaction in a patient with psoriatic arthritis.
Pallotta P; Cianchini G; Ruffelli M; Puddu P
Rheumatology (Oxford); 2006 Jan; 45(1):116-7. PubMed ID: 16319094
[No Abstract] [Full Text] [Related]
25. Adalimumab in juvenile rheumatoid arthritis.
Taddio A; Marchetti F
N Engl J Med; 2008 Dec; 359(23):2495-6; author reply 2496-7. PubMed ID: 19065749
[No Abstract] [Full Text] [Related]
26. Pseudolymphomatoid cutaneous leishmaniasis in a patient treated with adalimumab for rheumatoid arthritis.
Baltà-Cruz S; Alsina-Glbert M; Mozos-Rocafort A; Cervera C; Colomo-Saperas L; Del Río A; Estrach-Panella T
Acta Derm Venereol; 2009; 89(4):432-3. PubMed ID: 19688168
[No Abstract] [Full Text] [Related]
27. Anti-TNF-alpha therapies: they are all the same (aren't they?).
Mpofu S; Fatima F; Moots RJ
Rheumatology (Oxford); 2005 Mar; 44(3):271-3. PubMed ID: 15561736
[No Abstract] [Full Text] [Related]
28. Severe polymyositis and flare in autoimmunity following treatment with adalimumab in a patient with overlapping features of polyarthritis and scleroderma.
Liozon E; Ouattara B; Loustaud-Ratti V; Vidal E
Scand J Rheumatol; 2007; 36(6):484-6. PubMed ID: 18092275
[No Abstract] [Full Text] [Related]
29. [Subacute cutaneous lupus erythematosus induced by golimumab].
Blasco-Morente G; Notario-Ferreira I; Rueda-Villafranca B; Tercedor-Sánchez J
Med Clin (Barc); 2015 Sep; 145(5):226-7. PubMed ID: 25547737
[No Abstract] [Full Text] [Related]
30. Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety.
Hyrich KL; Silman AJ
J Rheumatol; 2006 May; 33(5):831-3. PubMed ID: 16652412
[No Abstract] [Full Text] [Related]
31. Mycobacterium chelonae infection associated with adalimumab therapy.
Díaz F; Urkijo JC; Mendoza F; de la Viuda JM; Blanco M; Unzurrunzaga A; Ayarza R
Scand J Rheumatol; 2008; 37(2):159-60. PubMed ID: 18415777
[No Abstract] [Full Text] [Related]
32. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
33. Dermatomyositis in patients with rheumatoid arthritis during adalimumab therapy.
Nagashima T; Minota S
J Rheumatol; 2011 Mar; 38(3):574; author reply 575. PubMed ID: 21362792
[No Abstract] [Full Text] [Related]
34. Successful treatment of refractory lupus-associated haemophagocytic lymphohistiocytosis with infliximab.
Ideguchi H; Ohno S; Takase K; Hattori H; Kirino Y; Takeno M; Ishigatsubo Y
Rheumatology (Oxford); 2007 Oct; 46(10):1621-2. PubMed ID: 17726035
[No Abstract] [Full Text] [Related]
35. Adalimumab-induced asthma.
Bennett AN; Wong M; Zain A; Panayi G; Kirkham B
Rheumatology (Oxford); 2005 Sep; 44(9):1199-200. PubMed ID: 15870147
[No Abstract] [Full Text] [Related]
36. Anti-TNF-alpha-induced psoriasis: case report of an unusual adverse event.
Aslanidis S; Pyrpasopoulou A; Leontsini M; Zamboulis C
Int J Dermatol; 2006 Aug; 45(8):982-3. PubMed ID: 16911391
[No Abstract] [Full Text] [Related]
37. The appearance of pustular psoriasis during antitumor necrosis factor therapy.
Goncalves DP; Laurindo I; Scheinberg MA
J Clin Rheumatol; 2006 Oct; 12(5):262. PubMed ID: 17023816
[No Abstract] [Full Text] [Related]
38. Palmoplantar and scalp psoriasis occurring during anti-tumour necrosis factor-alpha therapy: a case series of four patients and guidelines for management.
Papadavid E; Gazi S; Dalamaga M; Stavrianeas N; Ntelis V
J Eur Acad Dermatol Venereol; 2008 Mar; 22(3):380-2. PubMed ID: 18269613
[No Abstract] [Full Text] [Related]
39. [Drug-induced systemic lupus erythematosus: reports to The Netherlands Pharmacovigilance Centre Lareb].
de Langen-Wouterse JJ; Bijl AM; van Grootheest AC
Ned Tijdschr Geneeskd; 2007 Feb; 151(6):367-70. PubMed ID: 17352303
[TBL] [Abstract][Full Text] [Related]
40. Tumor necrosis factor inhibition: a part of the solution or a part of the problem of heart failure in rheumatoid arthritis?
Gabriel SE
Arthritis Rheum; 2008 Mar; 58(3):637-40. PubMed ID: 18311805
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
